de Haan A - Search Results

1

The First-in-Human Synthetic Glycan-Based Conjugate Vaccine Candidate against Shigella.

van der Put RMF, Smitsman C, de Haan A, Hamzink M, Timmermans H, Uittenbogaard J, Westdijk J, Stork M, Ophorst O, Thouron F, Guerreiro C, Sansonetti PJ, Phalipon A, Mulard LA. van der Put RMF, et al. Among authors: de haan a. ACS Cent Sci. 2022 Apr 27;8(4):449-460. doi: 10.1021/acscentsci.1c01479. Epub 2022 Mar 17. ACS Cent Sci. 2022. PMID: 35559427 Free PMC article.

2

HPAEC-PAD method for the analysis of alkaline hydrolyzates of Haemophilus influenzae type b capsular polysaccharide.

de Haan A, van der Put RM, Beurret M. de Haan A, et al. Biomed Chromatogr. 2013 Sep;27(9):1137-42. doi: 10.1002/bmc.2918. Epub 2013 May 17. Biomed Chromatogr. 2013. PMID: 23681893

3

HPAEC-PAD quantification of Haemophilus influenzae type b polysaccharide in upstream and downstream samples.

van der Put RM, de Haan A, van den IJssel JG, Hamidi A, Beurret M. van der Put RM, et al. Among authors: de haan a. Vaccine. 2015 Nov 27;33(48):6908-13. doi: 10.1016/j.vaccine.2014.07.028. Epub 2014 Jul 19. Vaccine. 2015. PMID: 25045809

4

Trypsin diminishes the rat potency of polio serotype 3.

ten Have R, Westdijk J, Levels LM, Koedam P, de Haan A, Hamzink MR, Metz B, Kersten GF. ten Have R, et al. Among authors: de haan a. Biologicals. 2015 Nov;43(6):474-8. doi: 10.1016/j.biologicals.2015.07.010. Epub 2015 Aug 25. Biologicals. 2015. PMID: 26321654

5

Identification and optimization of critical process parameters for the production of NOMV vaccine against Neisseria meningitidis.

van de Waterbeemd B, Streefland M, van Keulen L, van den Ijssel J, de Haan A, Eppink MH, van der Pol LA. van de Waterbeemd B, et al. Among authors: de haan a. Vaccine. 2012 May 21;30(24):3683-90. doi: 10.1016/j.vaccine.2012.03.028. Epub 2012 Mar 30. Vaccine. 2012. PMID: 22464965

6

Aluminum Hydroxide And Aluminum Phosphate Adjuvants Elicit A Different Innate Immune Response.

Kooijman S, Vrieling H, Verhagen L, de Ridder J, de Haan A, van Riet E, Heck AJR, Kersten GFA, Pennings JLA, Metz B, Meiring HD. Kooijman S, et al. Among authors: de haan a, de ridder j. J Pharm Sci. 2022 Apr;111(4):982-990. doi: 10.1016/j.xphs.2022.01.014. Epub 2022 Jan 26. J Pharm Sci. 2022. PMID: 35090866

7

Vaccine-Mediated Activation of Human TLR4 Is Affected by Modulation of Culture Conditions during Whole-Cell Pertussis Vaccine Preparation.

Hoonakker ME, Verhagen LM, Pupo E, de Haan A, Metz B, Hendriksen CF, Han WG, Sloots A. Hoonakker ME, et al. Among authors: de haan a. PLoS One. 2016 Aug 22;11(8):e0161428. doi: 10.1371/journal.pone.0161428. eCollection 2016. PLoS One. 2016. PMID: 27548265 Free PMC article.

8

Expression of the lipopolysaccharide-modifying enzymes PagP and PagL modulates the endotoxic activity of Bordetella pertussis.

Geurtsen J, Steeghs L, Hamstra HJ, Ten Hove J, de Haan A, Kuipers B, Tommassen J, van der Ley P. Geurtsen J, et al. Among authors: de haan a. Infect Immun. 2006 Oct;74(10):5574-85. doi: 10.1128/IAI.00834-06. Infect Immun. 2006. PMID: 16988232 Free PMC article.

9

Modeling Neisseria meningitidis metabolism: from genome to metabolic fluxes.

Baart GJ, Zomer B, de Haan A, van der Pol LA, Beuvery EC, Tramper J, Martens DE. Baart GJ, et al. Among authors: de haan a. Genome Biol. 2007;8(7):R136. doi: 10.1186/gb-2007-8-7-r136. Genome Biol. 2007. PMID: 17617894 Free PMC article.

10

Modeling Neisseria meningitidis B metabolism at different specific growth rates.

Baart GJ, Willemsen M, Khatami E, de Haan A, Zomer B, Beuvery EC, Tramper J, Martens DE. Baart GJ, et al. Among authors: de haan a. Biotechnol Bioeng. 2008 Dec 1;101(5):1022-35. doi: 10.1002/bit.22016. Biotechnol Bioeng. 2008. PMID: 18942773

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

537 results

Search Page